MENU
+Compare
VIVS
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$1.82
Change
-$0.01 (-0.55%)
Capitalization
3.3M

VIVS VivoSim Lab Inc Forecast, Technical & Fundamental Analysis

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data... Show more

Industry: #Biotechnology
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VIVS with price predictions
Jun 04, 2025

VIVS's Stochastic Oscillator is staying in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVS advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

VIVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VIVS as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

VIVS moved below its 50-day moving average on May 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VIVS crossed bearishly below the 50-day moving average on May 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VIVS entered a downward trend on April 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VIVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.074) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). VIVS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (19.048) is also within normal values, averaging (265.014).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VIVS is expected to report earnings to -227 cents per share on May 22

VivoSim Lab Inc VIVS Stock Earnings Reports
Q1'25
Est.
$-2.28
Q4'24
Missed
by $2.04
The last earnings report on February 28 showed earnings per share of -228 cents, missing the estimate of -25 cents. With 22.16K shares outstanding, the current market capitalization sits at 3.30M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and commercializing functional human tissues

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRPH0.38N/A
+0.85%
ProPhase Labs
SYNA62.480.42
+0.68%
Synaptics
RGR35.75-0.04
-0.11%
Sturm Ruger & Company
FTI31.60-0.22
-0.69%
TechnipFMC plc
NCPL2.42-0.08
-3.04%
NETCAPITAL INC.

VIVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with GLTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+3.10%
GLTO - VIVS
38%
Loosely correlated
N/A
ORMP - VIVS
37%
Loosely correlated
+0.88%
ACET - VIVS
27%
Poorly correlated
+1.54%
KRRO - VIVS
26%
Poorly correlated
-0.42%
SLNO - VIVS
26%
Poorly correlated
-0.45%
More